Leuthold Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-22,531
| Closed | -$7.9M | – | 216 |
|
|
2025
Q4 | $7.9M | Buy |
+22,531
| New | +$7.61M | 0.85% | 37 |
|
|
2024
Q4 | – | Sell |
-12,700
| Closed | -$6.6M | – | 201 |
|
|
2024
Q3 | $6.6M | Sell |
12,700
-846
| -6% | -$452K | 0.73% | 50 |
|
|
2024
Q2 | $7.34M | Sell |
13,546
-1,572
| -10% | -$831K | 0.85% | 38 |
|
|
2024
Q1 | $7.84M | Sell |
15,118
-87
| -0.6% | -$43.3K | 0.88% | 35 |
|
|
2023
Q4 | $7.17M | Buy |
15,205
+231
| +2% | +$107K | 0.9% | 36 |
|
|
2023
Q3 | $6.52M | Buy |
14,974
+4,344
| +41% | +$1.97M | 0.91% | 27 |
|
|
2023
Q2 | $4.72M | Sell |
10,630
-1,598
| -13% | -$737K | 0.61% | 61 |
|
|
2023
Q1 | $5.62M | Sell |
12,228
-8,057
| -40% | -$3.83M | 0.74% | 44 |
|
|
2022
Q4 | $10.4M | Sell |
20,285
-467
| -2% | -$237K | 1.4% | 11 |
|
|
2022
Q3 | $9.43M | Sell |
20,752
-163
| -0.8% | -$78K | 1.42% | 11 |
|
|
2022
Q2 | $10.1M | Sell |
20,915
-547
| -3% | -$271K | 1.43% | 13 |
|
|
2022
Q1 | $10.5M | Buy |
21,462
+1,168
| +6% | +$534K | 1.35% | 15 |
|
|
2021
Q4 | $9.41M | Buy |
20,294
+9,017
| +80% | +$3.79M | 1.1% | 24 |
|
|
2021
Q3 | $4.2M | Sell |
11,277
-1,884
| -14% | -$716K | 0.52% | 75 |
|
|
2021
Q2 | $5.03M | Sell |
13,161
-252
| -2% | -$96.3K | 0.62% | 59 |
|
|
2021
Q1 | $4.82M | Sell |
13,413
-1,138
| -8% | -$366K | 0.61% | 62 |
|
|
2020
Q4 | $4.67M | Sell |
14,551
-861
| -6% | -$264K | 0.62% | 61 |
|
|
2020
Q3 | $4.14M | Sell |
15,412
-322
| -2% | -$86.6K | 0.57% | 60 |
|
|
2020
Q2 | $4.14M | Sell |
15,734
-370
| -2% | -$98.7K | 0.62% | 61 |
|
|
2020
Q1 | $3.66M | Buy |
16,104
+1,296
| +9% | +$353K | 0.66% | 56 |
|
|
2019
Q4 | $4.47M | Sell |
14,808
-577
| -4% | -$159K | 0.58% | 73 |
|
|
2019
Q3 | $3.69M | Sell |
15,385
-3,476
| -18% | -$952K | 0.48% | 86 |
|
|
2019
Q2 | $5.32M | Sell |
18,861
-22,256
| -54% | -$6.08M | 0.69% | 53 |
|
|
2019
Q1 | $11.8M | Sell |
41,117
-1,471
| -3% | -$425K | 1.59% | 8 |
|
|
2018
Q4 | $11.2M | Sell |
42,588
-4,933
| -10% | -$1.36M | 1.6% | 11 |
|
|
2018
Q3 | $13M | Buy |
47,521
+36
| +0.1% | +$9.35K | 1.42% | 14 |
|
|
2018
Q2 | $11.3M | Buy |
47,485
+3,240
| +7% | +$750K | 1.24% | 17 |
|
|
2018
Q1 | $9.72M | Sell |
44,245
-13,516
| -23% | -$3.18M | 1.11% | 16 |
|
|
2017
Q4 | $13M | Buy |
57,761
+6,718
| +13% | +$1.43M | 1.3% | 13 |
|
|
2017
Q3 | $9.69M | Buy |
51,043
+5,608
| +12% | +$1.07M | 0.98% | 21 |
|
|
2017
Q2 | $8.55M | Sell |
45,435
-752
| -2% | -$135K | 0.92% | 24 |
|
|
2017
Q1 | $7.64M | Sell |
46,187
-1,027
| -2% | -$163K | 0.82% | 29 |
|
|
2016
Q4 | $6.79M | Sell |
47,214
-4,359
| -8% | -$584K | 0.76% | 36 |
|
|
2016
Q3 | $6.46M | Sell |
51,573
-1,510
| -3% | -$195K | 0.68% | 54 |
|
|
2016
Q2 | $6.97M | Buy |
53,083
+6,048
| +13% | +$828K | 0.74% | 44 |
|
|
2016
Q1 | $6.54M | Buy |
47,035
+933
| +2% | +$125K | 0.71% | 51 |
|
|
2015
Q4 | $6.43M | Sell |
46,102
-55,942
| -55% | -$7.71M | 0.67% | 46 |
|
|
2015
Q3 | $14.3M | Sell |
102,044
-13,056
| -11% | -$1.96M | 1.51% | 7 |
|
|
2015
Q2 | $18.9M | Buy |
115,100
+3,760
| +3% | +$601K | 1.77% | 3 |
|
|
2015
Q1 | $17.2M | Buy |
111,340
+12,394
| +13% | +$1.76M | 1.6% | 5 |
|
|
2014
Q4 | $12.4M | Sell |
98,946
-20,877
| -17% | -$2.58M | 1.22% | 16 |
|
|
2014
Q3 | $14.3M | Sell |
119,823
-42,121
| -26% | -$4.83M | 1.29% | 8 |
|
|
2014
Q2 | $17.4M | Sell |
161,944
-242
| -0.1% | -$24.9K | 1.48% | 9 |
|
|
2014
Q1 | $16.1M | Buy |
162,186
+3,877
| +2% | +$351K | 1.43% | 9 |
|
|
2013
Q4 | $14.6M | Buy |
158,309
+68,753
| +77% | +$6.11M | 1.31% | 10 |
|
|
2013
Q3 | $7.49M | Buy |
89,556
+7,091
| +9% | +$608K | 0.69% | 36 |
|
|
2013
Q2 | $6.75M | Buy |
+82,465
| New | +$6.17M | 0.63% | 45 |
|
Other funds holding ELV
VCM
VPM
Leuthold Group's ELV Position: Q1 2026 in Review
Leuthold Group sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 22,531 shares — an estimated $7.9M sold.
Leuthold Group first reported a position in ELV in Q2 2013 and held it in 47 quarters. The position peaked at $18.9M in Q2 2015. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Leuthold Group reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Leuthold Group sold 22,531 Elevance Health shares in Q1 2026, an estimated $7.9M.
- Leuthold Group first reported a position in Elevance Health in Q2 2013 and held it in 47 quarters.
- Leuthold Group's Elevance Health position peaked at $18.9M in Q2 2015.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.